Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Elevance Health brought in $2.2 billion in profit for the first quarter of 2025, a figure that surpassed Wall Street's ...

Elevance Health Inc. earnings at a glance (GAAP ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with the ...

Elevance Health Inc. (NYSE: ELV) ended the first quarter of 2025 with better-than-expected financials. The company identified home health as one of its ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $478.00. The ...

Elevance Health will beat its earnings guidance for the first quarter despite high Medicare Advantage costs, the company announced Thursday. The health insurer reported that while Medicare ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024 and earned $45 billion in revenue in the quarter. For full-year 2024, Elevance reported $175.2 billion in revenue, an ...

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...